Stock Earnings: C&O

China-based C&O Pharmaceutical Technology (Holdings) Ltd's third quarter to March results: Sales - 83.95 mln hkd vs 70.86 mln
Pretax profit - 33.32 mln hkd vs 29.16 mln
Net profit - 27.32 mln hkd vs 23.43 mln
EPS (basic) - 4.4 HK cents vs 4.7

Nine months to March results:
Sales - 228.27 mln hkd vs 182.76 mln
Pretax profit - 88.47 mln hkd vs 70.67 mln
Net profit - 71.77 mln hkd vs 57.10 mln
EPS (basic) - 11.6 HK cents vs 11.4